Long coronavirus disease 19 (COVID-19) is the designation given to a novel syndrome that
develops within a few months after infection by severe acute respiratory syndrome …

A dysregulated immune response with high levels of SARS-CoV-2 specific IgG antibodies
characterizes patients with severe or critical COVID-19. Although a robust IgG response is …

The post COVID-19 syndrome (PCS) is an emerging phenomenon worldwide with
enormous socioeconomic impact. While many patients describe neuropsychiatric deficits …

Abstract Background Infections with SARS-CoV-2 have a pronounced impact on the
gastrointestinal tract and its resident microbiome. Clear differences between severe cases of …

Summary Background SARS-CoV-2-specific adaptive immunity more than 1 year after initial
infection has not been well characterised. The aim of this study was to investigate the …

Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes
diverse clinical manifestations and tissue injuries in multiple organs. However, cellular and …

We have recently demonstrated in a double-blind randomized trial the beneficial effects of L-
Arginine in patients hospitalized for COVID-19. We hypothesize that one of the mechanisms …

SUMMARY SARS‐CoV‐2, the virus that causes coronavirus disease (COVID)‐19, has
become a persistent global health threat. Individuals who are symptomatic for COVID‐19 …

New strategies to rapidly develop broad-spectrum antiviral therapies are urgently required
for emerging and re-emerging viruses. Host-targeting antivirals (HTAs) that target the …

Structural and systemic inequalities can contribute to susceptibility to COVID-19 disease and
limited access to vaccines. Recognizing that Racialized and Indigenous Peoples may …